蒙特利尔计算机认知评估在艾滋病毒感染老年人中的有效性:试点研究
Akarin Hiransuthikul1,2, Thanapoom Taweephol3,4, Netchanok Timachai5
1Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. akarin.h@chula.ac.th.
BMC neurology
|October 2, 2025
概括
一个基于平板电脑的认知评估工具 (eMoCA) 显示,与传统的基于纸质的MoCA在艾滋病毒感染的老年人中存在中等相关性. 之前的触摸屏体验显著影响了eMoCA的有效性,影响了认知评估结果.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 传染性疾病 传染性疾病
背景情况:
- 艾滋病毒感染的老年人群经常经历神经认知方面的挑战.
- 认知评估对于管理这一人口群体的认知健康至关重要.
- 这项研究评估了一种数字认知评估工具,用于泰国艾滋病毒感染者老年人.
研究的目的:
- 确定纸质蒙特利尔认知评估 (MoCA) 和其基于平板电脑的版本 (eMoCA) 之间的有效性和一致性.
- 评估之前触摸屏体验对认知评估结果的影响.
主要方法:
- 患有艾滋病毒的老年人 (≥50岁) 完成了纸质版本和eMoCA版本.
- 参与者被随机分配到评估的顺序.
- 皮尔森相关性,一致性相关系数 (CCC) 和布兰德-阿尔特曼图分析了得分一致性.
- 参与者之间进行了分数的比较,有和没有之前的触摸屏体验.
主要成果:
- 这项研究包括46名参与者;26.1%的人以前有触摸屏的经验.
- 皮尔森相关性 (r=0.54) 和CCC (0.47) 表示纸张和eMoCA之间存在温和的协议.
- 与纸质MoCA相比,没有触摸屏体验的参与者在eMoCA上得分明显低 (平均差异-1.56).
结论:
- 与纸质MoCA相比,eMoCA显示了中等的有效性.
- 触摸屏体验是影响eMoCA准确性的关键因素.
- 在选择认知评估方法时,临床医生必须考虑患者的数字素养.
更多相关视频
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.3K
相关概念视频
Cognitive Development During Adulthood
780
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
780
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
